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Medicinal Plants Used in the
Management of Psychosis
Sunday Oritsetimenyin Otimenyin and Lydia Doosuur Ior
Abstract
Substantial number of studies has been conducted to find alternatives or treat-
ments for psychosis. Psychosis represents a variety of mental disorders character-
ized by the presence of delusions, hallucinations and grossly disorganized thinking
in a clear sensorium. Psychosis is burdensome and difficult to treat given the
inability of the typical and atypical antipsychotics to adequately manage it, accom-
panied by numerous disturbing adverse effects. Therefore, many with chronic
mental health problems justifiably feel disappointed by the apparent ineffectiveness
of conventional treatment and naturally search for a more holistic approach to
treatment and alternative medicines having less or no side-effects. Plants are rich in
secondary metabolites which have the ability to interact with the Central nervous
system (CNS) to produce effects that can be beneficial for the management of
psychosis, these phytochemicals are believed to have minimal adverse effects. A
review of some of the medicinal plants used as antipsychotics, indicated that many
medicinal plants possess antipsychotic effects that can improve the treatment of
psychosis. Apparently, further studies are necessary in order to isolate the active
constituents, ascertain their molecular mechanisms and safety, and also to test them
in clinical studies for the development of new pharmacotherapies for psychosis.
Keywords: Medicinal plants, Molecular mechanisms, Psychosis, Secondary
metabolites, Antipsychotics
1. Introduction
The term “psychosis” denotes a variety of mental disorders: the presence of
delusions, various types of hallucinations, usually auditory or visual, but sometimes
tactile or olfactory, and grossly disorganized thinking in a clear sensorium.
Schizophrenia is an enduring, disabling psychiatric illness affecting about 1% of the
population globally. It is characterized by various symptoms classified into positive,
negative and cognitive) [1, 2].
Plants provide the essential nutrients and remedy needed by humans, they are
healthier compared to animal diets. Over time much benefits have been derived
from medicinal plants due to their rich natural phytochemicals that interact
favorably with the human body and neurotransmitters to produce effects that are
beneficial to man. In this chapter we will look at some medicinal plant used in the
pharmacotherapy of psychosis.
1
2. Management of psychosis
Psychosis is an immense social and economic problem, but the management of
psychosis remains insufficient. Basically typical and atypical antipsychotics are used
for the treatment of schizophrenia, the typical antipsychotics such as chlorproma-
zine and haloperidol are only effective in the treatment of positive symptoms, and
are accompanied by disturbing adverse effects such as extrapyramidal side-effects
[3], the atypical antipsychotic drugs such as risperidone and olanzapine provide
some beneficial effects on negative symptoms and cognitive deficits [4], but they
are inadequate and mild. Prolonged use also results in increased oxidative load [5]
which could lead to cardiovascular disorders, diabetes, and agranulocytosis seen
with clozapine, they also cause moderate to severe weight gain [2, 6–8]. The use of
medicinal plants as complementary remedies for the treatment of psychosis have
become necessary because of their characteristically high chemical diversity, bio-
chemical specificity, and several other properties that make them favorable lead
structures for the treatment of various disorders, including psychosis [9], for
example, Alpinia zerumbet (Pers.) B. L. Burtt (Zingiberaceae) [10], Lonchocarpus
cyanescens (Schumach and Thonn.) Benth. (Fabaceae) [11] etc., which have been
used in the pharmacotherapy of psychosis. Interestingly many of these plants were
studied and found to have lesser side effects e.g. catalepsy [12–15] indicating that
these plants may not cause extrapyramidal side effects in humans.
Medicinal plants are either used as an alternative or in addition to orthodox
medicine [16], users search for a more holistic approach to treatment, others expect
that alternative medicines have less or no side-effects, and many with chronic
mental health problems justifiably feel disappointed by the apparent ineffectiveness
of conventional treatment [17].
3. Review of relevant pathophysiology
Neuropsychiatric Disorders may occur as a result of a number of factors such as
genetic predisposition, lifestyle factors such as substance abuse and recently diet is
also believed to be a factor [18] due to certain observations that associated incidence
of psychotic episodes in neuropsychiatric diseases with poor dietary patterns, such
as a lower intake of omega-3 fatty acids, vegetables, fibers, fruits, vitamins and
minerals [19], all these are substances that can be obtained naturally supporting the
use of natural products in psychosis especially because of the high antioxidant
content of these natural products, since oxidative stress is implicated in psychosis.
4. Secondary metabolites in medicinal plants for psychosis
The discovery of effective plant-based medicinal plants for the treatment of
psychosis is constrained by a need to conclusively identify relevant active constitu-
ents and understand synergies within them and an inability to sufficiently stan-
dardize replicable extracts.
A large number of natural phytochemicals are claimed to have beneficial effects
on the adequate functioning of the human brain [20]. Essentially, metabolites
produce effects on human brain function probably due to the connection between
plant, mammalian biochemistry and molecular functioning. Principally, as a result
of the numerous molecular signaling pathways that are conserved between taxa and
their role in the synthesis of secondary metabolite [21]. Secondly the effects might
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be based on the similarities between the prevalent natural herbivores of plants and
the nervous systems of humans. Therefore, the phytochemicals whose synthesis has
been retained by a process of natural selection and on the basis of their ability to
interact with the CNS of herbivorous or symbiotic insects will also interact with the
human CNS system via the same mechanisms [22]. Some of the significance of
secondary metabolites involve general protective roles (such as antioxidant, ultra
violet (UV) light-absorbing, free radical-scavenging and antiproliferative agents)
and preservation the plant against microorganisms such as bacteria, fungi, and
viruses. More intricate actions involve dictating or modifying the plant’s relation-
ship with more complex organisms [23–25]. This is achieved primarily by their role
of feeding deterrence, consequently, many phytochemicals are bitter and/or toxic
to potential herbivores, with this toxicity often extending to direct interactions with
the herbivore’s central and peripheral nervous systems [26] identified extracts and
constituents from 85 individual medicinal plants that have potential efficacy for
treating psychiatric disorder. Accordingly, secondary metabolites often act as ago-
nists or antagonists of neurotransmitter systems [25, 27] or form structural analogs
of endogenous hormones [28].
Secondary metabolites can be subdivided into many distinct groups base on their
chemical structure and synthetic pathways, furthermore, these groups can be
broadly categorized in terms of the nature of their ecological roles and also their
eventual effects and comparative toxicity in the consuming animal. The phyto-
chemicals are herewith, discussed base on the chemical nature of their alleged active
components. The largest and most widespread of phytochemical groups are the
alkaloids, phenolic compounds and terpenes.
4.1 Alkaloids
Alkaloids are a structurally diverse group of over 12,000 cyclic nitrogen-
containing compounds that are found in over 20% of plant species [29]. The use of
alkaloids for medicinal purposes dates as far back as the Stone Age [20].
The alkaloids are known to be the common poisons, neurotoxins, and traditional
psychedelics for example atropine, scopolamine, and hyoscyamine, from Atropa
Belladonna plant and social drugs such as ephedrine, nicotine, opiates, cocaine, and
caffeine widely consumed for recreational purposes [30]. Despite their posoinous
nature, this group of chemicals also found application in the treatment of
Alzheimer’s Disease, because of their cholinesterase inhibiting effects e.g.
riverstigmine, huperzine, physostigmine, and huperzine [31].
Gentianine is a major alkaloid extracted from Swertia chirata Linn
(Gentianaceae), it was reported to possess antipsychotic activity in experimental
animals by antagonizing amphetamine induced stereotypy [32]. 11-demethoxyre-
serpiline, 10- demethoxyreserpiline, α-yohimbine and reserpiline are alkaloids
isolated from the leaves of Rauwolfia tetraphylla and are found to possess atypical
antipsychotic-like actions [33]. alstonine an indole alkaloid isolated from Picralima
nitida Alstonine was found to possess antipsychotic properties [34, 35].
4.2 Phenolic compounds
Phenolic compounds are universally found across the plant kingdom, with
approximately 10,000 structures identified to date. Phenolics are synthesized from
precursors produced by the phenylpropanoid pathway with the exception of a few
notable compounds. Structurally, they share at least one aromatic hydrocarbon ring
with one or more hydroxyl groups attached [22].
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Phenolic compounds comprise of simple low-molecular weight compounds,
such as the coumarins, simple phenylpropanoids, and benzoic acid derivatives, to
more complex structures such as flavanoids, tannins and stilbenes [22]. These
compounds play an important role in CNS functioning by interacting directly with
neurotransmitter systems. In in vivo models, phenolics enhance cognition through
antagonistic gamma-aminobutyric acid (GABA) receptor binding, with resultant
cholinergic upregulation and exert antidepressant effects via monoamine oxidase
inhibition in the brain, sedative, anxiolytic and antipsychotic effects by binding to
GABA receptors, [36–38]. Flavonoids are widely distributed throughout the plant
kingdom. They are constituents of medicinal plants used as herbal medicines in
traditional medical practice, and are now considered valuable therapeutic agents in
modern medicines [39, 40]. Many studies have reported that flavones modulate
neurotransmission through enhancement of GABA activity in the central nervous
system; which led to the hypothesis that they could exert tranquilizing effects in
behavioral hyperactivity such as schizophrenia [41, 42]. Undeniably, a number of
evidences have implicated the role of altered GABAergic transmission in the patho-
physiology of schizophrenia [43, 44]. Morin a flavonoid isolated from plants was
found to exhibit antipsychotic effects [45].
4.2.1 Tannins
Tannins are a group of plant secondary metabolites that have the ability to tan or
convert animal skin into leather. These compounds are classified as being water
soluble phenolics with the ability to precipitate alkaloids, gelatins, and other pro-
teins. High tannin concentrations are found in nearly every part of many plants,
such as in the bark, wood, leaves, fruit, roots, plant galls, and seed. Tannins may
exert their biological effects in two different ways: as unabsorbables, these are
usually complex structures with binding properties which may produce local effects
in the gastrointestinal tract (antioxidant, radical scavenging, antimicrobial,
antiviral, antimutagenic, and antinutrient effects), or as absorbable, these are usu-
ally low molecular weight structures which are easily absorbed, and produce sys-
temic effects in various organs [46]. Gallic acid, a gallotanin found in many plants
was reported to demonstrate anti-schizophrenic activity primarily due to its anti-
oxidant and anti-inflammatory effects [47]. A novel tannin composition effective in
treating mental diseases such as acute or chronic schizophrenia, was isolated from
Rhubarb (Rhe; Rhi zoma) a kind of crude drug known from the past and has been
frequently used as a Japanese-Chinese medicine [48].
4.2.2 Saponins
Saponins are naturally occurring, but functionally and structurally diverse phy-
tochemicals that are broadly distributed in plants. They are a complex and chemi-
cally varied group of compounds consisting of triterpenoid or steroidal glycones
linked to oligosaccharide moieties. Although there is a scarce documentation on the
antipsychotic potential of saponin, polygalasaponins, a saponin isolated from
Polygalae tenuifolia was reported to possessed antipsychotic effects [49].
4.3 Terpenes
Terpenes are a diverse group of more than 30,000 lipid-soluble compounds.
Their structure includes 1 or more 5-carbon isoprene units, Terpenoids are classified
base on the number of isoprene units they contain; isoprene, which itself is synthe-
sized and released by plants, comprises 1 unit and is classified as a hemiterpene;
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monoterpenes incorporate 2 isoprene units, sesquiterpenes incorporate 3 units,
diterpenes comprise 4 units, sesterpenes include 5 units, triterpenes incorporate
6 units, and tetraterpenes 8 units [22]. Some of the recognized antipsychotic terpe-
noids are myrcene, beta-caryophyllene and limonene. However, these terpenoids
do not only have antipsychotic properties but possess anti-depressant effects due to
the suppression and activation of the cannabinoid receptor 2 [20].
5. Review of medicinal plants for psychosis
Many medicinal plants are in use both in developed and developing countries for
the treatment of psychosis, some of these plants have been studied for their anti-
psychotic properties whereas most of these plants have no scientific backings for
their efficacy. Literature search of the PUBMED and Sciencedirect journals have
documented a number of plants studied for their antipsychotic properties in labo-
ratory animals, however, most of the studies carried out are preliminary, and the
need for further studies to isolate the active constituents, determine the mechanism
of action and conduct clinical trials to verify their efficacy and safety is necessary.
Table 1 gave a list of some of the reviewed antipsychotic plants, their constituents
and probable mechanism of action.
6. Efficacy of natural plants in the treatment of psychosis
Many medicinal plants studied for psychosis were found to have efficacy against
the positive, negative and cognitive deficit of schizophrenia in laboratory animals,
without the disturbing adverse effects seen with conventional antipsychotic drugs.
Even those that are thought to act on the dopamine receptors had minimal or no
cataleptic tendencies. The tendency for these plants to ameliorate the negative
symptoms in schizophrenia, and in some cases also improve psychotic symptoms,
may be owing to the ability of most plants to generally exert anti-inflammatory
effects [71] and given that inflammation is a risk factor in most neuropsychiatric
disorders including schizophrenia [72]. Oxidative stress is also a major factor in
psychosis, plants contain diverse constituents which exhibit antioxidant, and
neuroprotective effects useful in ameliorating psychotic symptoms [67].
Large number of schizophrenic patients fail to respond adequately to the initial
antipsychotic drug treatment necessitating the addition of natural antipsychotic
plants to their treatment regimen. As recently reviewed by Hoenders et al. [73] the
inclusion of traditional medicine or Ayurvedic herbs to antipsychotics, generally
improve the psychopathology of the disease, however, more studies are needed to
conclusively support this finding.
7. Molecular mechanisms of antipsychotic action of medicinal plants
Many medicinal plants have been studied for their antipsychotic properties and
several mechanisms of action have been proposed for their actions. A number of
these plants were believed to act in a similar manner as orthodox medicines but in
most cases without the disturbing adverse effects. Table 1 gave a summary of the
probable antipsychotic mechanism of action of the medicinal plants. Various animal
models are used to investigate the antipsychotic properties of medicinal plants,
some of these models help to determine whether these plants have typical or
atypical antipsychotic like effects.
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Plant name Parts used Constituents and effects Probable mechanism of action Author
Albizia zygia (DC.) J.F. Macbr.
(Leguminosae)
Roots The root extract of Albizia zygia is used to manage
mental disorders in African traditional medicine.
Some of the phytochemical constituents are
flavonoids, alkaloids, tannins and saponins. The
extract exhibited an antipsychotic-like activity in
mice with potential to alleviate positive, negative and
cognitive symptoms of schizophrenia.
The possible mechanism of action of Albizia zygia
may be related to enhancement of N-methyl-D-




Alpinia zerumbet Leaves The essential oil was extracted from the leaves of
Alpinia zerumbet, the major constituents are 1,8-
cineole and terpinen4-ol which may be responsible
for the antipsychotic effects observed from the plant.
The possible mechanism of action might be due to




Alstonia scholaris Linn. R.Br. (Apocynaceae) Leaves Alstonia scholaris is used widely in the treatment of
anxiety, depression and other mental illnesses. The
plant was found to possess antipsychotic effects.
Mechanism of action may be attributed to dopamine




Bacopa monniera (Linn.) (Scrophularia-ceae) Whole
plant
Triterpenoid, saponins, and bacosides are considered
to be the major constituents in the plant. Bacopa
monniera has been reported to possess antipsychotic,
anxiolytic and other medicinal properties.
The antipsychotic properties may be related to its
normalization of dopamine and serotonergic




Brassica Oleracea Var. sabellica (Brassicaceae) Leaf Juice Brassica oleracea possess excellent phytoconstituents
such as flavonoids and polyphenols and is widely
used as dietary supplements. It has antioxidant and
anti-inflammatory properties, and was found to
possess antipsychotic properties.
Brassica oleracea increase GABA levels resulting in
the control of dopaminergic neurotransmission
which may be its possible mechanism of action.
Yadav et al.
[51]
Cannabis sativa Linn. (Cannabaceae) Leaves Cannabidiol one of the major constituent of Cannabis
sativa leaves possesses atypical antipsychotic-like
properties in humans and laboratory animals.
The possible mechanism of C. sativa may be due to
enhancement of NMDA receptors located on
















Plant name Parts used Constituents and effects Probable mechanism of action Author
Crassocephalum bauchiense (Hutch.) Milne-
Redh (Asteraceae)
Leaves Crassocephalum bauchiense is a medicinal herb
effective in the cases of cerebral deficit, anxiety,
epilepsy, cerebral malaria, neuropathic pain, and
behavioral disturbances in mentally retarded
children. The plant contains alkaloid that was found
to possess promising antipsychotic properties.
The antipsychotic properties are possibly mediated
via the GABAergic neurotransmission as well as
blockade of dopamine D-2 receptors
Taıwe et al.
[53]
Crinum Giganteum (Amarylli-daceae) Bulb alkaloids, saponins and tannins were found to be
some of the major constituents of Crinum giganteum,
the plant is used traditionally for various medicinal
purposes including psychiatric illnesses. The extract
of C. giganteum was found to possess antipsychotic
effects in laboratory animals
The possible mechanism of action of Crinum




Desmodium adscendens (Sw.) DC (Fabaceae) Whole
plant
The major constituent in Desmodium adscendens is
alkaloid, it is a medicinal herb with several uses
including psychosis. The extract was found to possess
antipsychotic effects against apomorphine induced
climbing and stereotypic behavior.




Embelia ribes Burm.f (Myrsinaceae) Ber-ries Embelin was isolated from Embelia ribes and found
to be responsible for the antipsychotic effect of the
plant. Embelin reversed apomorphine induced
stereotypic behavior, confirming its antipsychotic
potential.
Embelin action may be due dopamine antagonism
and decreased level of neurotransmitters such as
dopamine, serotonin and noradrenaline as well as
antioxidant effects.
Durg et al. [55]
Guiera senegalensis J. F. Gmel (Combretacea) Stem bark Guiera senegalensis is rich in tannin and known to
possess varying medicinal effects. The extracts
attenuated amphetamine-induced stereotyped
behavior in mice suggesting that the plant possess
antipsychotic properties that can be useful as a safe
alternative.
The effect of the extract amphetamine-induced
stereotyped behavior in mice suggest anti-










































Plant name Parts used Constituents and effects Probable mechanism of action Author
Lonchocarpus cyanescens (Schumach and
Thonn.) Benth. (Fabaceae)
Leaves Lonchocarpus cyanescens is reputed for its used in
traditional medicine for the treatment of Psychosis.
Studies have shown that Lonchocarpus cyanescens
contains various active principles such as quercetin,
kaempferol, loncocarpin, and rhamnetin which may
be responsible for its antipsychotic activity.
Lonchocarpus cyanescens was found to possess
antipsychotic properties.
The probable mechanism of action of Lonchocarpus
cyanescens might be due to antidopaminergic effects.
Arowona et al.
[57]
Maytenus obtufisolia Mart. (Celastraceae) Roots Triterpenes has been identified in Maytenus
obtufisolia, it is known that terpenes have
pharmacological actions on animal behavior.
Findings revealed the antipsychotic effects of M.
obtufisolia
The probable mechanism of action of Maytenus
obtufisoliamight be via a central dopaminergic action
de Sousa & de
Almeida. [58]
Morinda citrifolia Linn (Rubiaceae) Fruits scopoletin, rutin and quercetin are the major
constituents of Morinda citrifolia. The plant has so
many Uses for CNS disorders. The fruit juice was
found to possess antipsychotic properties.
The probable mechanism of antipsychotic effect of




Nauclea laltifolia Smith (Rubiaceae) Root bark Saponins are present in abundance in the extract and
might contribute in part for the observed CNS
effects. The extract demonstrated antipsychotic
effects by attenuating apomorphine induced
stereotypic behavior
The effect of the extract against apomorphine is




Newbouldia laevis Seem. (Bignoniaceae) Stem bark Newbouldia laevis is a medicinal plant used in the
treatment of various ailments. The plant contains
alkaloids and saponins which might be responsible
for its neuroleptic effects. The extract ofN. laeviswas
found to possess antipsychotic effects.
The probable mechanism of action might be due to















Plant name Parts used Constituents and effects Probable mechanism of action Author
Ocimum sanctum (Lamiaceae) Leaves Ocimum sanctum have been reported for their
pharmacological actions including anti-oxidant, anti-
stress, and anticonvulsant. The plant contains
flavonoids, essential oil, Caffeic acid and vitamins.
Ocimum sanctum leaves possesses anti-psychotic like
property.
The Probable mechanism of action include
antioxidant action and enhancement of NMDA
neurotransmission as well as neuroprotection.
Sharma et al.
[62]
Panax quinquefolium Linn (Araliaceae) Leaves The plant’s major compound is ginseng which is
known to possess numerous pharmacological effects.
Panax quinquefolium extract was effective against
negative and cognitive dysfunctions induced by
ketamine
The antipsychotic properties may be related to its
normalization of dopamine and serotonergic




Picralima nitida Stampf Th. et H.Dur.
(Apocynaceae)
Fruits alstonine an indole alkaloid isolated from Picralima
nitida a plant commonly used by traditional
psychiatrist as part of the treatment of psychosis.
Alstonine was found to possess antipsychotic
properties experimental profile comparable with that
of clozapine and is compatible with the alleged
effects in mental patients.
Alstonine indirectly modulates DA receptors,
specifically by modulating DA uptake, it also
decreases glutamate uptake in acute hippocampal
slices. Alstonine also increases serotonergic




Piper guineense Schum & Thonn (Piperaceae) Fruits Piper guineense is a medicinal plant used in the
Southern States of Nigeria to treat fever, mental
disorders and febrile convulsions. β-
sesquiphellandren is an essential oil isolated from the
plant and was found to possess antipsychotic effects.
The antipsychotic activity may be mediated through
augmentation of GABA at the GABAA–
benzodiazepine receptor complex pathway, or




Polygala tenuifolia Willdenow (Polygalaceae) Roots Polygala tenuifolia Willdenow has been prescribed for
hundreds of years to treat psychotic illnesses in
Korean traditional medicine. Studies have found
polygasaponin to be the major constituent
responsible for its antipsychotic effect.
polygalasaponin molecular mechanism of action is











































Plant name Parts used Constituents and effects Probable mechanism of action Author
Rauwolfia tetraphylla L. (Syn. R. canescens/R.
heterophylla/ R. hirsuta; (Apocynaceae)
Leaves 11-demethoxyreserpiline, 10- demethoxyreserpiline,
α-yohimbine and reserpiline are alkaloids isolated
from the leaves of Rauwolfia tetraphylla and are
found to possess atypical antipsychotic-like actions
The mechanism of action of the plant is due to the




Rhodiola rosea Linn. (Crassulaceae) The extracts of R. rosea are used in traditional
medicine for various conditions related to nervous
system function. Studies has shown that the extract
has beneficial antipsychotic properties.
The probable antipsychotic mechanism of R. rosea is




Saururus cernuus Linn. (Sauru-ruraceae) Saururus cernuus has been used in folk medicine as a
sedative and to treat other illnesses. Manassantin A. a
neolignoid isolated from Saururus cernuus was found
to demonstrate neuroleptic activity
The antipsychotic effect of Saururus cernuus may be
due to weak antagonism of dopamine receptors.
Rao et al. [65]
Securinega virosa (Roxb ex. Willd) Baill. Root Bark Securinega virosa has been described as “cure all” in
Africa traditional medicine because of its use widely
in the treatment of many illnesses. The plant contains
saponins, flavonoids, alkaloids and tannins, and was
found to possess antipsycotic activity
The probable mechanism of action may be due to
dopamine D1 and D2 antagonism.
Magaji et al.
[66]
Spinacia oleracea Linn Chenopo-diaceae Seeds Spinacia oleracea is reported to have beneficial effect
against several neurodegenerative disorders.
Phytoconstituents such as ascorbic acid, apigenin,
astragalin, caffeic, lutein, β-carotene, ferulic acid,
kampeferol, rutin, querecetin were isolated from the
plant. The seed extract of Spinacia oleracea showed
antipsychotic activity.
Spinacia oleracea’s protective effect in schizophrenia
may be associated with its regulating effect on
dopamine, GABA, acetylcholinesterase, glutathione,
malondialdehyde levels
Yadav [67]
Spondias mombin Linn. (Anacar-diaceae) Leaves Spondias mombin is a medicinal plant widely use in
the treatment of various ailments including mental
illness. The extract contains tannins, flavonoids and
saponins as its major constituents. S. mombin possess
typical antipsychotic-like effects.
The antipsychotic mechanism of S. mombin may be














Plant name Parts used Constituents and effects Probable mechanism of action Author
Swertia chirata Linn Gentianaceae) Leaves Gentianine is a major alkaloid isolated from Swertia
chirata and was found to possess antipsychotic
properties by antagonizing amphetamine induced
stereotypy.




Synedrella nodiflora (Linn.) Gaertn (family
Asteraceae)
The extract of the whole plant has demonstrated
anticonvulsant, sedative, in vitro antioxidant and
free radical scavenging properties as well as
antinociceptive properties in acute and neuropathic
pain. Synedrella nodiflora also possess antipsychotic
properties.
The probably mechanism of the antipsychotic
properties of Synedrella nodiflora might be due to
central dopamine receptor antagonism.
Amoateng et al.
[69]




The plant contains Flavonoids, saponins and tannins
in abundance which may be responsible in part for
the observed activities. T. macroptera has been used
traditionally for the treatment of hallucinations, and
has also being found to possess antipsychotic
properties in the ketamine-induced psychosis model.
T. macroptera possible mechanism of action may be
due to enhancement of NMDA receptors located on
inhibitory GABAergic neurons in the limbic and
subcortical brain regions and also its antioxidant
properties.
Ior et al. [12]
Viscum album Linn. (Lorantha-ceae) Viscum album is claimed in traditional medical
practice, to be useful in the treatment of psychosis
and insomnia. Some of the major constituents of the
extract are flavonoids and tannins. V. album was
found to possess antipsychotic properties.
The mechanism of action of Viscum album maybe












































Dopaminergic deregulation, hypofunction of NMDA receptors and
GABAergic activity, diminished cholinergic firing, neuroinflammation and
increased oxidative stress has been demonstrated to play a pathophysiological role
in schizophrenia [67].
The dopamine and amphetamine animal models are basically used to study the
typical antipsychotic effects of drugs, their action are similar to the conventional
antipsychotics such as haloperidol, chlorpromazine, fluphenazine and thioridazine.
The stereotypic behavior observed in animals following the administration of apo-
morphine a dopaminergic agonist, are attributed to stimulation of D1 and D2 recep-
tors [74, 75]. Mesolimbic and nigrostriatal dopaminergic pathways play key roles in
the mediation of locomotor activity and stereotyped behavior. Animal models used
for assessing antipsychotic drugs are established on the neurochemical hypothesis
of schizophrenia, which involve largely the neurotransmitters dopamine and gluta-
mate [76]. The antagonism of dopamine D2 receptors in the mesolimbic-
mesocortical system is thought to be the basis of the therapeutic actions of the
antipsychotic drugs, especially those active against hallucinations and delusions
[77]. The dopamine-based models usually employ apomorphine, a direct agonist, or
amphetamine, a drug that increases the release of this neurotransmitter and blocks
its re-uptake.
The term atypical refers to the reduced propensity of the of an agent to cause
undesirable motor side effects, but it is also used to describe agents with a different
pharmacological profile from the typical antipsychotics; several of these newer
antipsychotics improve the negative as well as the positive symptoms [78]. The
atypical antipsychotics are categorized base on their pharmacological properties.
These include serotonin–dopamine antagonists, multi-acting receptor- Targeted
antipsychotics, and dopamine partial agonists. [79]. Examples include clozapine,
quetiapine, risperidone, amisulpride, sertindole, zotepine and aripiprazole. The
dopamine dysregulation with hyperfunction of the mesolimbic dopamine system
was the original tenet theory underlying the basis of schizophrenia [80] and the
earliest animal models were established on the basis of pharmacological manipula-
tion in an endeavor to simulate this feature [81], which respond to agents that affect
primarily the dopaminergic system, but does not demonstrate the negative or cog-
nitive symptoms seen in schizophrenia [82]. In contrast, a widely used animal
model of schizophrenia involves the acute or repeated administration of sub-
anesthetic doses of ketamine [83]. In rodents, N-methyl-Daspartic acid receptor
(NMDAR) blockade induces hyperactivity, stereotypy, deficits in prepulse inhibi-
tion [84], social interaction and memory (Becker and Grecksch [85]), which models
the positive, negative and cognitive symptoms of schizophrenia, respectively [9].
Furthermore, studies have revealed that reactive oxygen species have a significant
role in the pathogenesis of many illnesses, particularly neurological and psychiatric
illnesses. [86] Oxidative stress may be a common pathogenic mechanism underly-
ing many major psychiatric disorders as the brain is relatively susceptible to oxida-
tive damage [87]. Previous study confirmed that oxidative stress damage occurs in
patients with schizophrenia and one possible therapeutic solution is to use antioxi-
dants [88]. Reports from some of the medicinal plants studied that delineate some
of the animal models used and their molecular mechanism of action are highlighted.
7.1 Morinda citrifolia Linn (Rubiaceae)
Morinda citrifolia (noni) is an evergreen tree that grows in open coastline areas
at sea level and in forest regions. Four doses (1, 3, 5, 10 g/kg) of the fruit extract of
noni were administered prior to apomorphine/ amphetamine administration and
observed for climbing behavior and stereotypy. The extract significantly decreased
12
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the apomorphine-induced cage climbing behavior and climbing time in mice in a
dose dependent manner. Demonstrating the antidopaminergic effect of the plant.
The plant was found to be rich in rutin and scopoletin which might have played a
role in the antipsychotic mechanism [60].
7.2 Securinega virosa (Roxb ex. Willd) Baill
Securinega virosa is a medicinal plant commonly used in Africa in the manage-
ment of epilepsy and other mental illnesses. The antipsychotic prospect of the
residual aqueous fraction of the plant was assessed by means of the apomorphine
induced stereotypic climbing behavior model and the swim induced grooming
model, all in mice. The effect of the fraction on haloperidol-induced catalepsy was
also assessed. The fraction inhibited the grooming behavior and attenuated the
climbing behavior of the mice. These action of S. virosa extract was associated to its
involvement with the dopamine D1 receptor. Therefore, the study confirmed the
antipsychotic potential of S. virosa in traditional medicine [66]. The observed
effects were ascribed to the presence of alkaloid, saponin, flavonoid and tannin in
the leaves.
7.3 Picralima nitida Stampf Th. et H. Dur.
Picralima nitida is the only species of the genus Picralima and it is related to
Hunteria and Pleiocarpa. it belongs to the apocynaceae family. P. nitida has widely
varied applications in West Africa folk medicine. The indole alkaloid alstonine was
identified as the major component of the fruit rind of P. nitida, a plant-based
treatment administered to psychotic patients in Nigeria [34]. Alstonine was given
prior to apomorphine/ amphetamine administration and observed for climbing
behavior and stereotypy, the effect of the alkaloid on haloperidol-induced catalepsy
was also assessed [89]. Further studies of alstonine showed a clear antipsychotic
profile in rodents, closer to atypical than to typical antipsychotics. Apparently,
apomorphine induced stereotypy and amphetamine-induced lethality were signifi-
cantly reduced by alstonine, suggesting a decrease in mesolimbic dopamine,
alstonine reversed haloperidol-induced catalepsy, indicating that nigrostriatal
dopamine transmission is not lessened [89]. Alstonine was found to reduce negative
symptoms, through a mechanism involving 5HT2A,C receptors, and reverses inter-
action deficits induced by MK801 [90]. Further studies by Linck et al. [35] indicated
that alstonine indirectly modified DA receptors, precisely by modifying DA uptake.
This unique mechanism for DA transmission modulation backs the antipsychotic-
like effects of alstonine and is attuned with its behavioral profile in mice and
apparent effects in patients. These findings may signify an innovation in the anti-
psychotic development field [35].
7.4 Panax quinquefolium Linn
Panax quinquefolium is a native plant of North America, but is now cultivated
widely and used in many countries. The plant contains dammarane type
ginsenosides as the major biologically active constituents particularly Rb1, Rd. and
Re ginsenoside saponins [91] which are responsible for most of its bioactive prop-
erties. A graded dose study with P. quinquefolium revealed differential effects
against the ketamine induced hyperactivity in the Digiscan animal activity monitor,
and blocked ketamine induced memory impairment in the passive avoidance para-
digm. In the chronic studies, P. quinquefolium attenuated the ketamine-enhanced
immobility in the forced swim test and did not produce extra-pyramidal side effects
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in bar test and wood block test of catalepsy. These behavioral effects were com-
pared with standard drugs haloperidol and clozapine. P. quinquefolium was also
found to reduced DA and 5-HT content after prolonged treatment. Furthermore,
P. quinquefolium extract reduced acetylcholinesterase activity and nitrate levels,
conversely it increased glutamate levels in hippocampus. Ultimately, the study
revealed that P. quinquefolium possess antipsychotic like properties, which may be
beneficial in predominant negative and cognitive symptoms of schizophrenia [9].
7.5 Spinacia oleracea Linn
Spinacia oleracea commonly known as spinach is endowed with a number of
medicinal properties [92]. Ethnopharmacological studies proposed that Spinacia
oleracea seeds have promising antioxidant, neuroprotective, anti-epileptic, anti-
alzheimer and anti-inflammatory effects [93–95]. The study evaluated the protec-
tive effects of Spinacia oleracea seed extract in an experimental model of ketamine-
induced schizophrenia in mice. Ketamine was used to induce stereotyped psychotic
symptoms in mice. Behavioral studies (locomotor activity, stereotypy, immobility
duration and memory retention) were carried out followed by biochemical, neuro-
chemical and cellular alterations in the brain. Chronic treatment with Spinacia
oleracea seed extract significantly attenuated stereotyped behavioral symptoms in
mice. Biochemical estimations revealed that the extract reduced lipid peroxidation
and restored total brain proteins. Likewise, Spinacia oleracea remarkably reduced
dopamine levels, acetylcholinesterase activity & inflammatory surge serum tumor
necrosis factor (TNF-α) and increased the levels of GABA and reduced glutathione
in mice. The results of the study indicated that the extract could ameliorate
ketamine-induced psychotic symptoms in mice, signifying a protective effect in the
treatment of schizophrenia. Moreover, its protective effect in schizophrenia may be
associated with its regulating effect on dopamine, GABA, acetylcholinesterase
enzymes, glutathione and malondialdehyde levels [67].
7.6 Terminalia macroptera Linn
Terminalia macroptera Guill. & Perr. (Combretaceae) is a medicinal plant used
commonly in Africa. Ethnomedicinal report from Mali mentions the decoction of
leaves of T. macroptera in treatment of epilepsy [96], and anxiolytic effects of T.
macroptera has also been reported by [97]. The study was carried out to investigate
the antipsychotic effects of T. macroptera in an experimental model of ketamine-
induced psychosis in mice. Ketamine and apomorphine were used to induce stereo-
typed psychotic behavioral symptoms in mice. Behavioral studies (stereotype
behavior, locomotor activity, immobility duration and memory retention) were
carried out to investigate the protective effect of the ethyl acetate fraction of T.
macroptera on ketamine-induced psychotic symptoms, repeated treatment with the
ethyl acetate fraction for 7 consecutive days significantly attenuated stereotyped
behavioral symptoms, immobility duration and memory deficit in mice. The study
revealed that T. macroptera could ameliorate psychotic symptoms indicating pro-
tective effects in psychosis. Agent that ameliorate ketamine induced psychotic
symptoms are generally thought to act in a similar manner as atypical antipsy-
chotics [12].
7.7 Crassocephalum bauchiense (Hutch.) Milne-Redh
Crassocephalum bauchiense is a medicinal plant with diverse medicinal uses. The
leaves decoction of C. bauchiense is effective in the treatment of epilepsy, cerebral
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malaria, cerebral deficit, anxiety and behavioral disturbances in mentally retarded
children. Likewise, an aqueous extract of the whole plant is useful in the treatment
of insomnia, psychosis and other central nervous system disorders, [98, 99]. The
antipsychotic effects of C. bauchiense extracts were evaluated using the apomor-
phine animal model of psychosis. The ability of the leaves extracts of C. bauchiense
to modify the duration of akinesia was observed in the catalepsy test. Furthermore,
gamma-aminobutyric acid concentrations in the brain of treated mice were also
estimated. The aqueous extract and the alkaloid fraction of C. bauchiense
attenuated the apomorphine-induced stereotypy and fighting, and had significant
fall of the body temperature. In biochemical experiments, the concentration of the
inhibitory amino acid, gamma-aminobutyric acid, was significantly increased in the
brain of animals treated with the aqueous extract of C. bauchiense. The results
revealed that the antipsychotic and sedative properties of C. bauchiense are
possibly mediated via the blockade of dopamine D-2 receptors and GABAergic
activation [54].
7.8 Alpinia zerumbet (Pers.) Burtt. et Smith
Alpinia zerumbet has important physiological and pharmacological functions,
such as antioxidative [100], anticancer [101], anti-inflammatory [102], and anti-
anxiety [103]. In phytotherapy, A. zerumbet is used to treat neuropsychiatric symp-
toms such as depression, stress and anxiety, but it is only recently that the central
nervous system (CNS) effects of the essential oil from the plant leaves have been
studied [10]. The essential oil of A. zerumbet (50, 100 and 200 mg/kg i.p.) was
administered once to mice to evaluate antipsychotic activity assessed by ketamine-
induced hyperlocomotion, hypnotic activity induced by sodium pentobarbital,
antioxidant effects (determination of lipid peroxidation and GSH levels), as well as
variations in nitric oxide levels (determination of nitrite content). The result
revealed that the extract at doses of 100 and 200 mg/kg prevented ketamine
hyperlocomotion, and at a dose of 200 mg/kg decreased sleep latency, while all
doses increased sleeping time. The in-vitro antioxidant capacity of the oil caused a
reduction in lipid peroxidation and increase in glutathione levels. The extract also
prevented the decrease in nitrite content caused by oxidative stress. The findings
indicate antipsychotic and antioxidant effects of the essential oil of A. zerumbet that
may have promising efficacy for the treatment of schizophrenia [10].
7.9 Albizia zygia (DC.) J.F. Macbr. (Leguminosae)
Albizia zygia is one such plant with numerous medicinal uses. A decoction of the
roots is used for the treatment of insanity [104]. Several compounds including two
novel oleanane-type saponins, zygiaosides A and B, were lately isolated from the
roots of A. zygia [105].
A. zygia effects were assessed against apomorphine-induced cage climbing,
ketamine induced hyperlocomotion, enhanced immobility, impaired social
interaction as well as novel object recognition. The propensity of the extract to
induce catalepsy and to attenuate haloperidol-induced catalepsy were also investi-
gated. Findings revealed that A. zygia extract significantly attenuated apomorphine-
induced climbing behavior as well as ketamine-induced hyperlocomotion, immo-
bility and object recognition deficits. Furthermore, the extract had no cataleptic
effect. The root extract of A. zygia therefore exhibited antipsychotic-like activity in
mice with potential to alleviate positive, negative and cognitive symptoms of
schizophrenia [51].
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8. Conclusions
Plants have been the mainstay for the treatment of diseases all over the world
before the development of conventional medicines. The interest in the therapeutic
uses of plants have been revived due to obvious reasons such as their safety,
availability, and affordability as well as their efficacy. Research on medicinal plant
have provided evidences for their use, and further studies in order to isolate the
active constituents and also to test them in clinical studies is important for the
development of new pharmacotherapies for psychosis.
Acknowledgements
The authors acknowledge all sources, and are grateful to the authors/editors of
all the articles, journals, and books from where the literature for this article has been
reviewed.
Conflict of interest
The authors declare no conflict of interest.
Author details
Sunday Oritsetimenyin Otimenyin and Lydia Doosuur Ior*
University of Jos, Jos, Nigeria
*Address all correspondence to: lidyshal@gmail.com
©2021 TheAuthor(s). Licensee IntechOpen. This chapter is distributed under the terms
of theCreativeCommonsAttribution License (http://creativecommons.org/licenses/
by/3.0),which permits unrestricted use, distribution, and reproduction in anymedium,




[1] Bhugra D (2005) The global
prevalence of schizophrenia. PLoS Med
2:e151 quiz e175
[2] Reus VI. Mental disorders. In:
Fauci AS, Braunwald E, Kasper DL,
Hauser SL, Longo DL, Jameson JL,
Loscalzo J, editors. Harrison’s principles
of internal medicine. McGraw-Hill, New
York. 2008.
[3] Lieberman JA. Effectiveness of
antipsychotic drugs in patients with
chronic Schizophrenia. N Engl J Med
2005;353 Suppl 12: S1209-S1217.
[4]Harvey PD, Green MF, Keefe RS,
Velligan DI. Cognitive functioning in
schizophrenia: a consensus statement on
its role in the definition and evaluation
of effective treatments for the illness. J
Clin Psychiatry. 2004; 65:361–372
[5] Kumari R, Chatterjee M, Singh S.
Oxidative stress: A novel treatment
target in psychiatric disorder. Int J
Pharm Sci Rev Res. 2011; 9:165–172
[6]Meltzer H. Antipsychotic agents and
lithium. In: Katzung BG, Masters SB,
Trevor AJ, editors. Basic and clinical
pharmacology. McGraw-Hill
Companies, New York. 2010.
[7]Meyer JM. Pharmacotherapy of
psychosis and mania. In: Brunton L,
Chabner B, Knollman B (eds) Goodman
and Gilman’s The pharmacological basis
of therapeutics. McGraw-Hill, New
York. 2011.
[8]Newcomer JW. (2005). Second-
generation (atypical) antipsychotics and
metabolic effects: A comprehensive
literature review. CNS Drugs 19: 1–93.
[9] Chatterjee M, Singh S, Kumari R,
Verma KA, Palit G. Evaluation of the
Antipsychotic Potential of Panax
quinquefolium in Ketamine Induced
Experimental Psychosis Model in Mice.
Neurochemical Research. 2012;37:
759-770.
[10] de Araújoa F, de Oliveira G,
Gomes P, Soares M, Silva M, Carvalho A,
Macêdo D. Inhibition of ketamine-
induced hyperlocomotion in mice by the
essential oil of Alpinia zerumbet: possible
involvement of an antioxidant effect.
Journal of Pharmacy and Pharmacology.
2011;63:1103-1110.
[11] Arowona IT, Sonibare MA,
Umukoro S. Antipsychotic property of
solvent-partitioned fractions of
Lonchocarpus cyanescens leaf extract in
mice. J Basic Clin Physiol Pharmacol.
2014;25(2):235–240.
[12] Ior LD, Otimenyin SO,
Okwuasaba FK. Antipsychotic-like effect
of ethyl acetate fraction of Terminalia
macroptera leaf in mice. IBRO Neurosci.
Reports. 2021; 10, 10: 83-89.
[13] Amoateng P, Adjei S, Osei-Safo D,
Kukuia KK, Karikari TK, Nyarko AK. An
ethanolic extract of Desmodium
adscendens exhibits antipsychotic-like
activity in mice Amoateng P, Adjei S,
Osei-Safo D, Kukuia KK, Karikari TK,
Nyarko AK. An ethanolic extract of
Desmodium adscendens exhibits
antipsychotic-like activity in mice. J
Basic Clin Physiol Pharmacol. 2017;1-12.
[14] Chatterjee M, Verma R, Kumari R,
Singh S, Verma A, Palit G.
Antipsychotic activity of standardized
Bacopa extract against ketamine-
induced experimental psychosis in mice:




[15] Jash R, Chowdary kA. Ethanolic
extracts of Alstonia Scholaris and
Bacopa Monniera possess neuroleptic
activity due to anti-dopaminergic effect.
Phcog. Res. 2014;6(1):46-51.
17
Medicinal Plants Used in the Management of Psychosis
DOI: http://dx.doi.org/10.5772/intechopen.100224
[16] Zimmerman RA. Thomspon IM Jr.
Prevalence of complementary medicine
in urologic practice. A review of recent
studies with emphasis on use among
prostate cancer patients. Urology Clinics
of North America. 29, 1-9.
[17]Werneke U, Turner T, Priebe S.
Complementary medicines in
psychiatry, Review of effectiveness and
safety. British Journal of Psychiatry.
2006;188:109-121.
[18] Skalicka-Woz’niaka K, Gertsch J.
Antipsychotic natural products. Annual
reports inmedicinal chemistry. 2020;1-35.
[19] Aucoin M, LaChance L, Cooley K,
Kidd S. Functional food for the




[20] Ajao AA, Alimii AA, Olatunji OA,
Balogun FO, Saheed SA: A synopsis of
anti- psychotic medicinal plants in
Nigeria. Trans Royal Soc. S.A. 2017;1-9.
[21] Schultz JC. Shared signals and the
potential for phylogenetic espionage
between plants and animals. Integr
Comp Biol. 2002; 42:454– 462.
[22] Kennedy D, Whiteman E. Herbal
Extracts and Phytochemicals: Plant
Secondary Metabolites and the
Enhancement of Human Brain
Function. American Society for
Nutrition. Adv. Nutr. 2011;2:32–50.
[23] Gershenzon J. The cost of plant
chemical defense against herbivory: a
biochemical perspective. In:
Bernays EA, editor. Insect-plant
interactions. Boca Raton (FL): CRC
Press; 1994. p. 105–173.
[24] Tahara S. A journey of twenty-five
years through the ecological
biochemistry of flavonoids. Biosci
Biotechnol Biochem. 2007; 71:
1387–1404.
[25]Wink M. Evolution of secondary
metabolites from an ecological and
molecular phylogenetic perspective.
Phytochemistry. 2003; 64:3–19.12.
Rattan RS. Mechanism of action of
insecticidal secondary metabolites of
plant origin. Crop Prot. 2010; 29:913–920
[26] Zhang ZJ. Therapeutic effects of
herbal extracts and constituents in
animal models of psychiatric disorders.
Life Sci. 2004; 75:1659–1699.
[27]Wink M. Interference of alkaloids
with neuroreceptors and ion channels.
Stud Nat Prod Chem. 2000; 21:3–122
[28]Miller AE, Heyland A. Endocrine
interactions between plants and
animals: Implications of exogenous
hormone sources for the evolution of
hormone signaling. Gen Comp
Endocrinol. 2010; 166:455–461
[29] Zulak K, Liscombe D, Ashihara H,
Facchini P. Alkaloids. Plant secondary
metabolism in diet and human health.
Oxford: Blackwell Publishing; 2006.
p. 102–136.
[30]Zenk MH, Juenger M. Evolution and
current status of the phytochemistry of
nitrogenous compounds.
Phytochemistry. 2007; 68:2757–2772.
[31]Mukherjee PK, Kumar V, Mal M,
Houghton PJ. Acetylcholinesterase
inhibitors from plants. Phytomedicine.
2007; 14:289–300
[32] Bhattacharya SK, Ghosal S,
Chaudhuri RK, Singh AK, Sharma P:
(1974). Chemical Constituents of
Gentianaceae XI: Antipsychotic Activity
of Gentianine. J. Pharm. Sci. 1974;63(8):
1341-1342.
[33]Gupta S, Khanna V, Maurya A,
Bawankule D, Shukla R, Pal A,
Srivastava SK. Bioactivity guided
isolation of antipsychotic constituents




[34] Linck VM, Herrmann AP, Piato AL,
Detanico BC, Figueiró M, Flório J,
Iwu MM, Okunji CO, Leal MB,
Elisabetsky E. Alstonine as an
antipsychotic: Effects on brain amines
and metabolic changes. Evid. Based
Complement. Alternat. Med. 2011;1–7.
[35] Linck VM, Ganzella M,
Herrmanna AP, Okunji OC, Souza DO,
Elisabetskya E. Original mechanisms of
antipsychotic action by the indole
alkaloid alstonine (Picralima nitida).
Phytomedicine. 2015;22:52–55.
[36]Dhawan K, Dhawan S, Sharma A.
Passiflora: a review update. J of
Ethnopharmacol. 2004; 94:1–23.
[37] Kim DH, Jeon SJ, Son KH, Jung JW,
Lee S, Yoon BH, Lee JJ, Cho YW,
Cheong, JH. The ameliorating effect of
oroxylin A on scopolamine-induced
memory impairment in mice.
Neurobiology of Learning and Memory.
2007; 87:536–546.
[38] Xu Y, Wang Z, You W, Zhang X,
Li S, Barish P, Vernon M, Du X, Li G.
Antidepressant-like effect of trans-
resveratrol: involvement of se- rotonin
and noradrenaline system. European
Journal of Neuropsychopharmacology.
2010; 20:405–413.
[39]Havsteen BH. The biochemistry and
medical significance of the flavonoids.
Pharmacol Ther 2002; 96: 67–202
[40] Fang SH, Hou YC, Chang WC.
“Morin sulfates/glucuronides exert anti-
inflammatory activity on activated
macrophages and decreased the
incidence of septic shock”. Life Sci
2003; 74: 743–756
[41]Marder M, Paladini AC. GABA-A
receptor ligands of flavonoid structure.
Curr Top Med Chem 2002; 2: 853–867
[42]Wang F, Shing M, Huen Y.
Neuroactive flavonoids interacting with
GABAA receptor complex. Curr. Drug
Targets CNS Neurol. Disord 2005; 4:
575–585
[43] Benes FM, Vincent SL,
Alsterberg G. Increased GABAA
receptor binding in superficial layers of
cingulate cortex in schizophrenics. J
Neurosci 1992;12: 924–929
[44] Lewis DA, Pierri JN, Volk DW et al.
Altered GABA neurotransmission and
prefrontal cortical dysfunction in
schizophrenia. Biol Psychiatry 1999; 46:
616–626
[45] Ben-Azu BA, Omogbiya IA,
Ajayi AM, Iwalewa EO: Morin
Pretreatment Attenuates Schizophrenia-
Like Behaviors in. Drug Res 2017; 6: 1-9.
[46] Sieniawska E, Baj T. Tannins. In
Plant Metabolites: Their Chemistry.
Elsevier. 2017;199-232.
[47] Yadav M, Jindal DK, Dhingra M,
Kumar A, Parle M, Dhingra S.
Protective effect of gallic acid in
experimental model of ketamine-
induced psychosis: possible behaviour,
biochemical, neurochemical and cellular
alterations. Inflammopharmacol.2018;
26:413-424.
[48]Nishioka I, Nonaka G, Fujiwara M,
Ueki S: Novel tannin composition -




[49] Chunga I, Moore NA, Ohc W,





[50] Kumbol VW, Abotsi WK,
Ekuadzi E, Wood E. Albizia zygia root
extract exhibits antipsychotic-like




Medicinal Plants Used in the Management of Psychosis
DOI: http://dx.doi.org/10.5772/intechopen.100224
[51] Yadav M, Parle M, Dhingra MS.
Protective effect of Brassica oleracea
juice against Ketamine-induced
stereotypic behaviours in mice. Journal
of Medicinal Plants Studies. 2017;5(1):
200-204.
[52] Zuardi A, Crippa J, Hallak J,
Moreira F, Guimarães F. Cannabidiol, a
Cannabis sativa constituent, as an
antipsychotic drug. Cannabidiol as an
antipsychotic drug Brazilian Journal of
Medical and Biological Research. 2006;
39:421-429.
[53] Taıwe GS, Bum EN, Talla E,
Dawe A, Moto FC, Ngoupaye G, De
Waard M. Antipsychotic and sedative
effects of the leaf extract of
Crassocephalum bauchiense (Hutch.)
Milne-Redh (Asteraceae) in rodents.
Journal of Ethnopharmacology. 2012;
143:213–220.
[54] Amos S, Binda L, Akah P,
Wambebe C, Gamaniel K. Central
inhibitory activity of the aqueous
extract of Crinum giganteum.
Fitoterapia. 2003;74:23-28.
[55]Durg S, Kumar N, Vandal R,
Dhadde SB, Thippeswamy BS,
Badami S. Antipsychotic activity of
embelin isolated from Embelia ribes: A
preliminary study. Biomedicine &
Pharmacotherapy. 2017;90:328–331.
[56] Amos S, Binda L, Vongtau HC,
Abbah J, Sambo N, Odim E, Gamaniel,
K. Sedative effefcts of the methanolic
extract of Newbouldia laevis in mice
and rats. Bollettino Chimico
Farmaceutico. 2002; 471-475.
[57] Arowona IT, Sonibare MA,
Umukoro S. Antipsychotic property of
solvent-partitioned fractions of
Lonchocarpus cyanescens leaf extract in
mice. J Basic Clin Physiol Pharmacol.
2014;25(2):235–240.
[58] de Sousa D, de Almeida RN.
Neuroleptic-Like Properties of the
Chloroform Extract of Maytenus
obtusifolia MART. Roots. Biol. Pharm.
Bull. 2005;224-225.
[59] Pandy V, Narasingam M,
Mohamed Z. Antipsychotic-like activity
of Noni (Morinda citrifolia Linn.) in
mice. BMC Complementary and
Alternative Medicine. 2012;12:186-194.
[60] Amos S, Abbah J, Chindo B,
Edmonda I, Binda L, Adzu B, Buhari S,
Odutola AA, Wambebea C Gamaniel K;
Neuropharmacological effects of the
aqueous extract of Nauclea latifolia
root bark in rats and mice. JEP. 2005:
53–57.
[61] AMOS S, Binda L, Vongtau HC,
Abbah J, Sambo N, Odim E,
Gamaniel K. Sedative effefcts of the
methanolic extract of Newbouldia laevis
in mice and rats. Bollettino Chimico
Farmaceutico. 2002;471-475.
[62] Sharma K, Parle M, Yadav M.
Evaluation of antipsychotic effect of
methanolic extract of Ocimum sanctum
leaves on laboratory animals. Journal of
Applied Pharmaceutical Science. 2016;6:
171-177.
[63]Oyemitan IA, Olayera OA, Alabi A,
Abass L, Elusiyan CA, Oyedeji AO,
Akanmu MA.
Psychoneuropharmacological activities
and chemical composition of essential
oil of fresh fruits of Piper guineense
(Piperaceae) in mice. Journal of
Ethnopharmacology, 2015;0378-8741.
[64]Coors A, Brosch M, Kahl E, Khalil R,
Michel B, Laub A, Fend M. Rhodiola
rosea root extract has antipsychotic-like
effects in rodent models of sensorimotor
gating. Journal of Ethnopharmacology.
2019;235:320–328.
[65] Rao KV, Puri VN, EI-Sawaf HA.
Further studies on the neuroleptic
profile of manassantin A. European




[66]Magaji MG, Mohammed M,
Magaji RA, Musa AM-A, Hussaini IM.
Evaluation of the antipsychotic potential
of aqueous fraction of Securinega virosa
root bark extract in mice. Metabolic
Brain Disease. 2014.
[67] Yadav M, Parle M, Sharma N,
Jindal DK, Bhidhasra A, Dhingra MS,
Dhingra S. Protective effects of Spinacia
oleracea seeds extract in an
experimental model of schizophrenia:
Possible behavior, biochemical,
neurochemical and cellular alterations.
Biomedicine & Pharmacotherapy. 2018;
105:1015–1025.
[68]AyokaA, aAkomolafe RO, IwalewaE,
AkanmuM, UkponmwanO. Sedative,
antiepileptic and antipsychotic effects of
Spondias mombin L. (Anacardiaceae) in
mice and rats. Journal of
Ethnopharmacology. 2006;103:166-175.
[69] Amoateng PA, Osei-safo D, Kukuia
KK, Bekoe EO, Karikari TK, Kombian
SB. Extract of Synedrella nodiflora (L)
Gaertn exhibits antipsychotic properties
in murine models of psychosis. BMC
Complementary and Alternative
Medicine. 2017;17:389- 40.
[70]Guptaa G, Kazmi I, AfzalM,
RahmanM, Saleem S, Ashraf S, Anwar F.
Sedative, antiepileptic and antipsychotic
effects of Viscum album L.
(Loranthaceae) inmice and rats. Journal of
Ethnopharmacology. 2012;141:810-816.
[71]Gertsch J. Viveros-Paredes JM.
Taylor P; Plant immunostimulants-
scientific paradigm or myths. JEP. 2011;
136:385–391
[72] Aricioglu, F.; Ozkartal, C. S.; Unal,
G.; Dursun, S.; Cetin, M.; Muller, N.
Bull. Clin. Psychopharmacol. 2016, 26,
329–444.
[73]Hoenders, H. J. R.; Bartels-Velthuis,
A. A.; Vollbehr, N. K.; Bruggeman, R.;
Knegtering, H.; de Jong, J. T. V. M. J.
Nerv. Ment. Dis. 2018, 206, 81–101.
[74] Seeman P: Brain dopamine receptor.
Pharmacol Rev 1980, 32:229–313.
[75] Stoff JC, Kebabian JW: Two
dopamine receptor: biochemistry
physiology and pharmacology. Life
Sci 1984, 35:2281–2296.
[76] Lipska BK, Weinberger DR: To
model a psychiatric disorder in animals:
schizophrenia as a reality test.
Neuropsychopharmacol 2000, 23:223–
239.
[77]Gardner DM, Baldessarini RJ,
Waraich P: Modern antipsychotic drugs:
a critical overview. Can Med Assoc J
2005, 172:1703–1711.
[78] Remington G. Understanding
antipsychotic “atypicality”: a clinical
and pharmacological moving target. J
Psychiatry also necessary in terms of
distinguishing between Neurosci 2003;
28: 275-284
[79]Horacek, J., Bubenikova-Valesova,
V., Kopecek, M., Palenicek, T., Dockery,
C., Mohr, P., & Hoschl, C. (2006).
Mechanism of Action of Atypical
Antipsychotic Drugs and the
Neurobiology of Schizophrenia. In CNS
Drugs (pp. 389-409). Czech Republic:
Adis Data Information BV.
[80]Murray RM, Lappin J, Di Forti M.
Schizophrenia: From developmental
deviance to dopamine dysregulation.
Eur Neuropsychopharmacol. 2008;18:
129- 134.
[81] Jones PB, Barnes TR,Davies L,DunG,
LloydH, Hayhurst KP,Murray RM,
Markwick A, Lewis SW. Randomized
controlled trial of the effect on quality of
life of second- vs first-generation
antipsychotic drugs in schizophrenia: Cost
Utility of the Latest Antipsychotic Drugs
in Schizophrenia Study (CUtLASS 1).
Arch Gen Psychiatry. 2006; 63:1079-1087.
[82] Featherstone RE, Rizos Z, Kapur S,
letcher PJ. A sensitizing regimen of
21
Medicinal Plants Used in the Management of Psychosis
DOI: http://dx.doi.org/10.5772/intechopen.100224
amphetamine that disrupts attentional
setshifting does not disrupt working or
longterm memory. Behav Brain Res.
2008; 189:170
[83] Bubenikova-Valesova V, Horacek J,
Vrajova M, Hoschl C. Models of
schizophrenia in humans and animals
based on inhibition of NMDA receptors.
Neurosci Biobehav Rev. 2008; 32:
1014-1023.
[84] Jentsch JD, Roth RH. The
neuropsychopharmacology of
phencyclidine: From NMDA receptor




[85] Becker A, Grecksch G. Ketamine-
induced changes in rat behavior: A
possible animal model of schizophrenia.
Test of predictive validity. Prog
Neuropsychopharmacol Biol Psychiatry.
2004; 28:1267- 1277.
[86]Ng FB, Dean O, Bush A; Oxidative
stress in psychiatric disorders: evidence
base and therapeutic implications. Int J
Neuropsychopharmacol 2008; 11: 851–
876.
[87] Yao JK, Reddy RD, van
Kammen DP. Oxidative damage and
schizophrenia: an overview of the
evidence and its therapeutic
implications. CNS Drugs 2001; 15:
287–310.
[88] Padurariu M, Ciobica A, Dobrin I,
Stefanescu C. Evaluation of antioxidant
enzymes activities and lipid
peroxidation in schizophrenic patients
treated with typical and atypical
antipsychotics. Neurosci Lett. 2010. 2;
479(3):317-20.
[89] Costa-Campos L, Elisabetsky E,
Lara DR, Carlson TJ, King SR, Ubillas R,
Nunes DS, Iwu MM, Nkemjika CO,
Ozioko A, Agwu CO. Antipsychotic
profile of alstonine: ethnopharmacology
of a traditional Nigerian botanical
remedy. ” Anais da Academia Brasileira
de Ciˆencias. 1990;71(2):189-201.
[90] de Moura Linck V, Herrmann AP,
Goerck GC et al. “The putative
antipsychotic alstonine reverses social
interaction withdrawal in mice,”
Progress in Neuropsychopharmacology
and Biological Psychiatry. 2008;32(6):
1449–1452.
[91] Zhu S, Zou K, Fushimi H, Cai S,
Komatsu K. Comparative study on
triterpene saponins of Ginseng drugs.
Planta Med. 2004; 70:666–677.
[92] Yadav, M. Parle, M. Kadian, K.
Sharma, A review on psychosis and anti-
psychotic plants, Asian. J. Pharm. Clin.
Res. 8 (2015) 24–28.
[93] Kumar GR, Hypolipidemic activity
of Spinacia oleracea L. in atherogenic
diet induced hyperlipidemic rats, J. Bio.
Pharm. Res. 1 (2012) 39–43.
[94] Verma R, Sisodia R, Bhatia AL. Role
of Spinacia oleracea as antioxidant: a
biochemical study on mice brain after
exposure of gamma radiation, Asian. J.
Exp. Biol. Sci. 17 (2003) 51–57.
[95] Sultana R, Perluigi M. Butterfield,
Protein oxidation and lipid peroxidation
in brain of subjects with Alzheimer’s
disease: insights into mechanism of
neurodegeneration from redox
proteomics, Antioxid. Redox Signal. 8
(2006) 2021–2037.
[96] Pham, AT, Malterud, K. E., Paulsen,
B. S., Diallo, D., &Wangensteen, H.
(2011). DPPH Radical Scavenging and
Xanthine Oxidase Inhibitory Activity of
Terminalia macroptera Leaves. Natural
Product Communications, 6(8), 1125 -
1128.
[97] Bum EN, Neteydji S, Djafsia G,
Njifutie N, Taiwe GS, Rakotonirina SV,




anxiolytic and antipyretic activities in
mice. Asian J. Pharm. Health Sci. 2012;
2,4: 555–561.
[98] Adjanohoun JE, Aboukakar N,
Dramane K, Ebot ME, Ekpere JA, Enow-
Orock EG, Focho D, Gbile ZO,
Kamanyi A, Kamsu KJ, Keita A,
Mbenkum T, Mbi CN, Mbiele AL,
Mbome IL, Mubiru NK, Nancy WL,
Nkongmeneck B, Satabu B, Sofowora A,
Tamze V, Wirmum CK. Traditional
medicine and pharmacopoeia.
Contribution to Ethnobotanical and
Floristic Studies in Cameroon. Centre de
Production de Manuels Scolaires, Porto-
Novo (Rep. Du Benin). 1996; 133
[99] Biholong M, Contribution a l’e ´tude
de la flore du Cameroun: les
Aste’race’es. These de doctorat.
Universite ´ de Bordeaux III, Bordeaux.
France. 1986;10–50
[100] Xuan TD, Khanh TD, Khang D,
Quan NT, Elzaawely AA. Changes in
chemical composition, total phenolics
and antioxidant activity of Alpinia
(Alpinia zerumbet) leaves exposed to
UV. Int Lett Nat Sci. 2016; 55:25–34.
[101] Junior WA, Gomes DB,
Zanchet B, Schönell AP, Diel KA,
Banzato TP, et al. Antiproliferative
effects of pinostrobin and 5,6-
dehydrokavain isolated from leaves of
Alpinia zerumbet. Rev Bras Farmacogn.
2017;27(5):592–598.
[102] Anuthakoengkun A, Itharat A.
Inhibitory effect on nitric oxide
production and free radical scavenging
activity of Thai medicinal plants in
osteoarthritic knee treatment. J Med
Assoc Thai. 2014 Aug;97 Suppl 8:S116–
S124.
[103] de Sousa DP, de Almeida Soares
Hocayen P, Andrade LN, Andreatini R.
A systematic review of the anxiolytic-
like effects of essential oils in animal
models. Molecules. 2015;20(10):18620–
18660.
[104] Bouquet A, Debray M. Plantes
médicinales de la Côte d’Ivoire. Travaux
et Documents de l’orstom No. 32,
orstom, Paris, 1974.
[105]Noté OP. Simo L, Mbing JN.
Guillaume D, Aouazou SA, Muller CD,
Pegnyemb DE, Lobstein A.Two new
triterpenoid saponins from the roots of
Albizia zygia (DC.) JF Macbr,




Medicinal Plants Used in the Management of Psychosis
DOI: http://dx.doi.org/10.5772/intechopen.100224
